GL1X · GenesisL1 explorer

MolNFT v1 · #23289 · protein

The structure of ERK2 in complex with a small molecule inhibitor

1TVO · Mitogen-activated protein kinase 1: “The structure of ERK2 in complex with a small molecule inhibitor”. X-ray diffraction, 1 ligand (FRZ), 5 pockets (best druggability 0.69). MolNFT v1 #23289 on GenesisL1: 3D structure, binding…

PDB
1TVO
Type
protein
Length
350 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.1.37
UniProt
P28482
Ligands
FRZ
Pockets
5 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.1.37)protein35037% helix, 14% strandP28482

Ligands and binding sites

  • FRZ · 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1H-pyrazolo[3, 4-c]pyridazin-3-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13810.690.8134FRZ
21560.520.7931empty
3680.420.8120empty
41080.400.7619empty
5530.290.7512empty

Compared structures

  • 1TVO · The structure of ERK2 in complex with a small molecule inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.